doi: 10.1016/s0140-6736(70)90815-9.
Varicella and cytosine arabinoside
- PMID: 4190397
- DOI: 10.1016/s0140-6736(70)90815-9
Item in Clipboard
Varicella and cytosine arabinoside
Lancet.
.
No abstract available
Similar articles
-
[Cytosine arabinoside in the treatment of severe herpes zoster and varicella].Ned Tijdschr Geneeskd. 1972 Jan 29;116(5):200. Ned Tijdschr Geneeskd. 1972. PMID: 5028760 Dutch. No abstract available.
-
Cytosine arabinoside and herpes zoster.Lancet. 1971 Sep 25;2(7726):712. doi: 10.1016/s0140-6736(71)92288-4. Lancet. 1971. PMID: 4105748 No abstract available.
-
Failure of cytarabine in varicella-zoster infections.JAMA. 1973 Apr 2;224(1):122-3. JAMA. 1973. PMID: 4347648 Clinical Trial. No abstract available.
-
The management of varicella and zoster infections.Infect Dis Clin North Am. 1987 Jun;1(2):367-82. Infect Dis Clin North Am. 1987. PMID: 3332795 Review.
-
Therapeutic approaches to varicella-zoster virus infections.J Infect Dis. 1992 Aug;166 Suppl 1:S51-7. doi: 10.1093/infdis/166.supplement_1.s51. J Infect Dis. 1992. PMID: 1378081 Review.
Cited by
-
Cytosine arabinoside therapy for herpes simplex encephalitis--clinical experience with six patients.Antimicrob Agents Chemother. 1973 Mar;3(3):412-7. doi: 10.1128/AAC.3.3.412. Antimicrob Agents Chemother. 1973. PMID: 4790599 Free PMC article.
-
Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains.Antimicrob Agents Chemother. 1972 Apr;1(4):354-7. doi: 10.1128/AAC.1.4.354. Antimicrob Agents Chemother. 1972. PMID: 4364937 Free PMC article.